OsstemImplant Co Ltd
KOSDAQ:048260
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
OsstemImplant Co Ltd
KOSDAQ:048260
|
KR |
|
M
|
Metro Inc
F:62M
|
CA |
|
B
|
Bruker Corp
F:BKD
|
US |
|
Anheuser Busch Inbev SA
XETRA:1NBA
|
BE |
|
Banco do Brasil SA
F:BZLA
|
BR |
|
Azul SA
OTC:AZULD
|
BR |
|
C
|
Commonwealth Bank of Australia
F:CWW0
|
AU |
|
Newmont Corporation
NYSE:NEM
|
US |
|
W
|
WW International Inc
XMUN:WW6
|
US |
|
Oracle Power PLC
F:9OC
|
UK |
|
I
|
Industrial and Commercial Bank of China Ltd
F:ICK
|
CN |
|
H
|
Hargreaves Lansdown PLC
SWB:DMB
|
UK |
|
Kadokawa Corp
TSE:9468
|
JP |
|
En Japan Inc
TSE:4849
|
JP |
|
Kone Oyj
F:KC40
|
FI |
|
Acuren Corp
NYSE:TIC
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is OsstemImplant Co Ltd's stock price target?
Not Available
OsstemImplant Co Ltd does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for OsstemImplant Co Ltd?
Projected CAGR
20%
Over the last 8 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 3 years is 20%.
What is the Operating Income forecast for OsstemImplant Co Ltd?
Projected CAGR
17%
Over the last 8 years, the compound annual growth rate for Operating Income has been 30%. The projected CAGR for the next 3 years is 17%.